In chronic myeloid leukaemia (CML), a chromosomal translocation occurs to generate a new fusion gene, BCR-ABL, which is transcribed into the constitutively active fusion protein BCR-ABL,114 being the main driver of this disease. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.